Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Capital Expenditures (2016 - 2021)

Medicure has reported Capital Expenditures over the past 11 years, most recently at -$40460.1 for Q4 2021.

  • For Q4 2021, Capital Expenditures changed N/A year-over-year to -$40460.1; the TTM value through Dec 2021 reached -$184417.4, changed N/A, while the annual FY2022 figure was -$10313.8, 96.55% up from the prior year.
  • Capital Expenditures for Q4 2021 was -$40460.1 at Medicure, up from -$131077.5 in the prior quarter.
  • Over five years, Capital Expenditures peaked at -$3737.0 in Q2 2019 and troughed at -$869067.7 in Q3 2017.
  • A 4-year average of -$186050.8 and a median of -$64098.9 in 2018 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: tumbled 4142.29% in 2017 and later surged 99.03% in 2018.
  • Year by year, Capital Expenditures stood at -$869067.7 in 2017, then soared by 93.9% to -$53033.4 in 2018, then surged by 75.71% to -$12879.7 in 2019, then tumbled by 214.14% to -$40460.1 in 2021.
  • Business Quant data shows Capital Expenditures for MCUJF at -$40460.1 in Q4 2021, -$131077.5 in Q3 2021, and -$12879.7 in Q3 2019.